Latest Articlesddd
Compugen to Present Data Update on COM701 Phase 1 Clinical Trial at the 2020 AACR Virtual …
Moderna Therapeutics Virtual Vaccine Day On April 7, 2020 Moderna Therapeutics (MRNA) announced that it will …
A Comprehensive Essay Part 4 Our fair evaluation approaches of biotechnology and biopharma companies differ depending …
Novavax Identified an "Ideal" Coronavirus Vaccine Candidate The news from Novavax (NVAX) informs that the firm …
COVID-19 at Its Peak? The number of deaths from the COVID-19 outbreak in NYC are expected …
Presenting Fate Therapeutics Today we are presenting Fate Therapeutics (FATE); a clinical-stage company developing programmed cellular immunotherapies …
Presenting UroGen Pharma UroGen Pharma (URGN) focuses on cancers and urologic diseases. It announced its fourth quarter …
Vertex and Regeneron Will Survive the Coronavirus Market Vertex We picked Vertex (VRTX) on March 18, …
COVID-19 and the Nation's Hospitals Disagreeable news with regard to the nation's hospitals is their unpreparedness …
Exelixis, Takeda and Japanese RCC Patients Today we learned from Exelixis (EXEL) that Takeda Pharmaceutical Company …
The Week in Review #49 The Stars from the Weeks Preceding the Novel Coronavirus Outbreak Forty …
Coronavirus: The Possible Treatments While Moderna’s (MRNA) vaccine is being tested and its stock price continued …
A Market in Chaos The Market is in chaos. When this happens the market needs to …
COVID-19, The Market Rebounding and the Biotech Firms That Did and Didn't Rally The Market Rebounding …
Stock Market Fluctuations and Volatility Only history can remind us that what’s going on recently with …
Compugen Soaring in an Extremely Down Market The stocks' prices tumbled today except for very few …
NanoViricides and COVID-19 NanoViricides (NNVC), a development-stage nano-biopharmaceutical company with a proprietary and patented drug development …
Treating and Preventing COVID-19 Treating COVID-19, Gilead Sciences With regard to treating patients with COVID-19 we …
The Market Soared Being optimistic about the greatness of American scientific capability does not mean underestimating …
Gilead Sciences to Acquire Forty Seven Gilead Sciences (GILD) and Forty Seven (FTSV) announced today that the companies …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
